<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2022-2-423-428</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-1869</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL &amp; EXPERIMENTAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Оценка эффективности лечения синдрома сухого глаза при сахарном диабете</article-title><trans-title-group xml:lang="en"><trans-title>Assessment of Efficiency of Dry Eye Therapy in Diabetes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6252-3622</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бахритдинова</surname><given-names>Ф. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bahritdinova</surname><given-names>F. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор кафедры офтальмологии,</p><p>ул. Фароби, 2, Ташкент, 700109</p></bio><bio xml:lang="en"><p>MD, professor of the Department of ophthalmology,</p><p>Faroby str., 2, Tashkent, 100109</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0842-7028</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миррахимова</surname><given-names>С. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Mirrakhimova</surname><given-names>S. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, доцент кафедры глазных болезней,</p><p>ул. А. Темура, 18. Самарканд, 100400</p></bio><bio xml:lang="en"><p>MD, associated professor of the department of eye diseases,</p><p>A. Temur str., 18, Samarkand, 140100</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8795-017X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Набиева</surname><given-names>И. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Nabieva</surname><given-names>I. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>соискатель,</p><p>проспект Мирзо Улугбека, 56, Ташкент, 100056</p></bio><bio xml:lang="en"><p>postgraduate,</p><p>Mirzo Ulugbeka ave., 56, Tashkent, 100056</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8705-3740</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орипов</surname><given-names>О. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Oripov</surname><given-names>O. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры офтальмологии,</p><p>ул. Фароби, 2, Ташкент, 700109</p></bio><bio xml:lang="en"><p>assistant of the ophthalmology department,</p><p>Faroby str., 2, Tashkent, 100109</p></bio><email xlink:type="simple">okil.oripov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ташкентская медицинская академия</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>Tashkent Medical Academy</institution><country>Uzbekistan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Самаркандский государственный медицинский институт</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>Samarkand State Medical Institute</institution><country>Uzbekistan</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Республиканский специализированный научно-практический медицинский центр эндокринологии</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>Endocrinology Medical Center</institution><country>Uzbekistan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>06</day><month>07</month><year>2022</year></pub-date><volume>19</volume><issue>2</issue><fpage>423</fpage><lpage>428</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бахритдинова Ф.А., Миррахимова С.Ш., Набиева И.Ф., Орипов О.И., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Бахритдинова Ф.А., Миррахимова С.Ш., Набиева И.Ф., Орипов О.И.</copyright-holder><copyright-holder xml:lang="en">Bahritdinova F.A., Mirrakhimova S.S., Nabieva I.F., Oripov O.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/1869">https://www.ophthalmojournal.com/opht/article/view/1869</self-uri><abstract><sec><title>Цель</title><p>Цель: провести сравнительную оценку клинико-функциональной эффективности препаратов заменителей слезы «Кератроп» и «Слезол» у пациентов с синдромом сухого глаза (ССГ) на фоне сахарного диабета (СД).</p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы. Исследование включало 89 пациентов (178 глаз) с выявленными диагнозами ССГ легкой и средней степени. Все пациенты были разделены на 3 группы: основная группа — 30 пациентов, которым закапывали препарат «Кератроп» 2 раза в сутки в течение 14 дней; группа сравнения — 30 пациентов, которым закапывали препарат «Слезол» 2 раза в день в течение 14 дней; контрольная группа — 29 пациентов — препараты «искусственной слезы» не закапывали. Для определения объективных показателей ССГ проводилось исследование слезопродукции (проба Ширмера), времени разрыва слезной пленки (ВРСП) и мейбография.</p></sec><sec><title>Результаты</title><p>Результаты. После окончания курса лечения положительная динамика симптомов наблюдалась во всех трех группах. Однако у пациентов основной группы, применявших препарат «Кератроп», динамика как субъективных, так и объективных симптомов оказалась более выраженной. У пациентов основной группы наблюдались достоверно более низкие показатели выраженности субъективной и объективной симптоматики, а также более высокие показатели ВРСП по сравнению с показателями сравнительной и контрольной группы. При этом профиль переносимости препарата «Кератроп» оказался более благоприятным по субъективным оценкам пациентов в сравнении с препаратом «Слезол».</p></sec><sec><title>Заключение</title><p>Заключение. Препарат «Кератроп» обладает высокой терапевтической эффективностью и благоприятным профилем переносимости при инстилляциях у пациентов с проявлениями ССГ, обусловленными СД. </p></sec></abstract><trans-abstract xml:lang="en"><p>The organ of vision is one of the target organs, which is negatively influenced by a number of harmful factors of the working environment and the labor process. Under their influence, the functioning of the visual analyzer can be disrupted, the risk of developing various diseases and injuries increases. The problem of the ophthalmopathology development in persons employed in hazardous industries is relevant, since the protection of the health of the working-age population is of great socio-economic importance. The proposed review of the literature presents the structure and frequency of occurrence of ophthalmopathology in workers of the cement industry, oil refining and petrochemical industries, metallurgical industry, coal and mining industries, manganese ore industry, synthetic rubber production, rubber technical products, synthetic ethyl alcohol, bakery, aviation production, also workers of the underground and railways of the main professions, including those who service underground tunnels. The data of the nosological structure of ophthalmopathology of various hazardous industries workers in Ukraine, India, and some African countries are presented. Among the professionally conditioned pathology of the vision organ, diseases of the anterior part of the eyeball are most common: chronic conjunctivitis, blepharitis, blepharoconjunctivitis, dry eye syndrome. In the general diseases’s structure of the vision organ, the first place is occupied by anomalies of refraction (from 14.3 to 88.9 %). The share of eye injuries ranges from 4 to 12.5 %. The frequency of occurrence of various ophthalmopathologies increases among workers with more than 10–15 years professional experience, which is typical for all industries and industries; there is also a direct connection between diseases of the organ of vision and the class of harmfulness of working conditions. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>синдром сухого глаза</kwd><kwd>лечение синдрома сухого глаза</kwd><kwd>заменители слезы</kwd><kwd>слезная пленка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes</kwd><kwd>dry eye syndrome</kwd><kwd>treatment of dry eye syndrome</kwd><kwd>substitutes for tears</kwd><kwd>tear film</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бржеский В.В. Синдром «сухого глаза» у детей: современные возможности диагностики и лечения (в помощь практическому врачу). Российская педиатрическая офтальмология. 2017;2:73–81.</mixed-citation><mixed-citation xml:lang="en">Brzheskiy V.V. Dry eye syndrome in children: modern possibilities of diagnostics and therapy (for doctors). Russian Pediatric Ophthalmology = Rossiiskaya pediatricheskaya oftal’mologiya. 2017;2:73–81 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Stevenson W. Dry eye disease. Archives of Ophthalmology. 2012;1(130):90–100. DOI: 10.1001/archophthalmol.2011.364</mixed-citation><mixed-citation xml:lang="en">Stevenson W. Dry eye disease. Archives of Ophthalmology. 2012;1(130):90–100. DOI: 10.1001/archophthalmol.2011.364</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Прозорная Л.П., Бржеский В.В. Сравнительная эффективность применения препаратов «Искусственной слезы» у пациентов с синдромом «Сухого глаза» на фоне хронического блефарита. Педиатр. 2013;1:53.</mixed-citation><mixed-citation xml:lang="en">Prozornaya L.P., Brzheskiy V.V. Comparative effectiveness of “artificial tear” drops use in patients wirh dry eye syndrome assosiated with blepharatis. Pediatr = Pediatr. 2013:1:53 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Трубилин В.Н., Полунина Е.Г., Алиева А.Э., Куренков В.В., Жемчугова А.В. Новая диагностическая методика комплексной оценки морфо-функционального состояния мейбомиевых желез — биометрия мейбомиевых желез. Офтальмология. 2014;11(2):39–47. DOI: 10.18008/1816-5095-2014-239-47</mixed-citation><mixed-citation xml:lang="en">Trubilin V.N., Polunina E.G., Alieva A.E., Kurenkov V.V., Zhemchugova A.V. A novel method of complex evaluation of meibomian glands morphological and functional state. Ophthalmology in Russia  = Oftal’mologiya. 2014;11(2):39–47 (In Russ.). DOI: 10.18008/1816-5095-2014-239-47</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Трубилин В.Н., Седнева Т.А., Капкова С.Г. Слезозаместительная терапия в профилактике и лечении синдрома «сухого глаза» после катарактальной хирургии. Офтальмология. 2013;10(1):56–62. DOI: 10.18008/1816-5095-2013-1-56-62</mixed-citation><mixed-citation xml:lang="en">Trubilin V.N., Sedneva T.A., Kapkova S.G. The tear substitutive therapy for prophylaxis and treatment of dry eye after cataract surgery. Ophthalmology in Russia = Oftal’mologiya. 2013;10(1):56–62 (In Russ.). DOI: 10.18008/1816-5095-2013-1-56-62</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y. Prevalence and control of diabetes in Chinese adults. The Journal of the American Medical Association. 2013;310:948–959. DOI: 10.1001/jama.2013.168118</mixed-citation><mixed-citation xml:lang="en">Xu Y. Prevalence and control of diabetes in Chinese adults. The Journal of the American Medical Association. 2013;310:948–959. DOI: 10.1001/jama.2013.168118</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lemp M.A. Advances in understanding and managing dry eye disease. American Journal of Ophthalmology. 2008;146:350–356. DOI: 10.1016/j.ajo.2008.05.016</mixed-citation><mixed-citation xml:lang="en">Lemp M.A. Advances in understanding and managing dry eye disease. American Journal of Ophthalmology. 2008;146:350–356. DOI: 10.1016/j.ajo.2008.05.016</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gekka M.K., Miyata Y., Nagai Corneal epithelial barrier function in diabetic patients. Conea. 2004;1:35–37. DOI: 10.1097/00003226-200401000-00006</mixed-citation><mixed-citation xml:lang="en">Gekka M.K., Miyata Y., Nagai Corneal epithelial barrier function in diabetic patients. Conea. 2004;1:35–37. DOI: 10.1097/00003226-200401000-00006</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liu H., Sheng M., Y. Liu Expression of SIRT1 and oxidative stress in diabetic dry eye. International Journal of Clinical and Experimental Pathology. 2015;6(8):7644–7653.</mixed-citation><mixed-citation xml:lang="en">Liu H., Sheng M., Y. Liu Expression of SIRT1 and oxidative stress in diabetic dry eye. International Journal of Clinical and Experimental Pathology. 2015;6(8):7644–7653.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Beckman K.A. Characterization of dry eye disease in diabetic patients versus nondiabetic patients. Cornea. 2014;8(33):851–854. DOI: 10.1097/ico.0000000000000163</mixed-citation><mixed-citation xml:lang="en">Beckman K.A. Characterization of dry eye disease in diabetic patients versus nondiabetic patients. Cornea. 2014;8(33):851–854. DOI: 10.1097/ico.0000000000000163</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Imam S., Elagin R.B., Jaume J.C. Diabetes-associated dry eye syndrome in a new humanized transgenic model of type 1 diabetes. Molecular Vision. 2013;19:1259–1267. DOI: 10.1210/endo</mixed-citation><mixed-citation xml:lang="en">Imam S., Elagin R.B., Jaume J.C. Diabetes-associated dry eye syndrome in a new humanized transgenic model of type 1 diabetes. Molecular Vision. 2013;19:1259–1267. DOI: 10.1210/endo</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Achtsidis V., Eleftheriadou I., Kozanidou E. Dry eye syndrome in subjects with diabetes and association with neuropathy. Diabetes Care. 2014;10(37):210–211. DOI: 10.2337/dc14-0860</mixed-citation><mixed-citation xml:lang="en">Achtsidis V., Eleftheriadou I., Kozanidou E. Dry eye syndrome in subjects with diabetes and association with neuropathy. Diabetes Care. 2014;10(37):210–211. DOI: 10.2337/dc14-0860</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Misra S.L., Patel D.V., McGhee C.N. Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus. Journal of Diabetes Research. 2014:6. DOI: 10.1155/2014/848659</mixed-citation><mixed-citation xml:lang="en">Misra S.L., Patel D.V., McGhee C.N. Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus. Journal of Diabetes Research. 2014:6. DOI: 10.1155/2014/848659</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dias A.C., Batista T.M., Roma L.P. Insulin replacement restores the vesicular secretory apparatus in the diabetic rat lacrimal gland. Arquivos Brasileiros de Oftalmologia. 2015;3(78):158–163. DOI: 10.5935/0004-2749.20150041</mixed-citation><mixed-citation xml:lang="en">Dias A.C., Batista T.M., Roma L.P. Insulin replacement restores the vesicular secretory apparatus in the diabetic rat lacrimal gland. Arquivos Brasileiros de Oftalmologia. 2015;3(78):158–163. DOI: 10.5935/0004-2749.20150041</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Li B., Sheng M., Xie L Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. Investigative Ophthalmology and Visual Science. 2014;1(55):177–186.</mixed-citation><mixed-citation xml:lang="en">Li B., Sheng M., Xie L Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. Investigative Ophthalmology and Visual Science. 2014;1(55):177–186.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Li B., Sheng M., Xie L. Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. Investigative Ophthalmology &amp; Visual Science January 2014;55:177–186. DOI: 10.1167/iovs.13-12080</mixed-citation><mixed-citation xml:lang="en">Li B., Sheng M., Xie L. Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. Investigative Ophthalmology &amp; Visual Science January 2014;55:177–186. DOI: 10.1167/iovs.13-12080</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fuerst N., Langelier N., Massaro-Giordano M. Tear osmolarity and dry eye symptoms in diabetics. Clinical Ophthalmology. 2014;8:507–515. DOI: 10.2147/opth. s51514 18. Hessen M., Akpek E.K. Dry eye: an inflammatory ocular disease. Journal of Ophthalmic and Vision Research. 2014;2(9):240–250. PMID: 25279127</mixed-citation><mixed-citation xml:lang="en">Fuerst N., Langelier N., Massaro-Giordano M. Tear osmolarity and dry eye symptoms in diabetics. Clinical Ophthalmology. 2014;8:507–515. DOI: 10.2147/opth. s51514 18. Hessen M., Akpek E.K. Dry eye: an inflammatory ocular disease. Journal of Ophthalmic and Vision Research. 2014;2(9):240–250. PMID: 25279127</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
